Roland Chapurlat

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Henry G. Bone, Rachel B. Wagman, Maria Luisa Brandi et al. · The Lancet Diabetes & Endocrinology · 2017 · 961 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Obesity Is Not Protective against Fracture in Postmenopausal Women: GLOW

Juliet Compston, Nelson B. Watts, Roland Chapurlat et al. · The American Journal of Medicine · 2011 · 551 citations · Full text

Medicine, Endocrinology, Orthopedic Surgery +11

Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study

Elizabeth J. Samelson, Kerry E Broe, Hanfei Xu et al. · The Lancet Diabetes & Endocrinology · 2018 · 394 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15

Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography

Danielle E. Whittier, Steven K. Boyd, Andrew J. Burghardt et al. · Osteoporosis International · 2020 · 353 citations · Full text

Medicine, Orthopedic Surgery, Radiology +14

Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension

Socrates E. Papapoulos, Roland Chapurlat, Cesar Libanati et al. · Journal of Bone and Mineral Research · 2011 · 344 citations · Full text

Medicine, Orthopaedic Surgery, Bone Metabolism +14